Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. R. Yigit

Publicaties

Evaluation of BRCA1/2 testing rates in epithelial ovarian cancer patients: lessons learned from real-world clinical data

Evaluation of the recently established Dutch nationwide Archipelago of Ovarian Cancer Research biobank

Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial

B cells critical for outcome in high grade serous ovarian carcinoma

Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families

Effect of surgical volume on short-term outcomes of cytoreductive surgery for advanced-stage ovarian cancer: A population-based study from the Dutch Gynecological Oncology Audit

High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers

Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma

Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers

Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study

Pers/media

Krebsvorstufen wegimpfen

La vacuna contra el VPH ‘muy prometedora’ para rechazar lesiones precancerosas

HPV Vaccine ‘Very Promising’ for Nixing Precancerous Lesions

Zervixkarzinom: Neuer HPV-Impfstoff beseitigt vorhandene CIN-3-Läsionen

Experimental HPV vaccine shrinks high-grade precancerous cervical lesions

A Therapeutic HPV Vaccine Could Eliminate Precancerous Cervical Lesions

Cervical cancer: HPV vaccine to get rid of precancerous lesions

New HPV vaccine shows promise in treating high-grade cervical lesions